Clinical Trials Directory

Trials / Completed

CompletedNCT02605655

Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome

Phase 0 Clinical Trial of Chinese Formula AMP-1915 on Metabolic Syndrome

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Shanghai University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the Chinese formula AMP-1915 has effect on Metabolic Syndrome (MS) in MS patients. Half of patients received AMP-1915, while the other half received placebo.

Detailed description

In China, the herbal formulas have been used in the treatment of diabetes for centuries. Huangqisan, investigators named it AMP-1915, is one of traditional Chinese herbal formula used to relieve diabetes which was recorded in Shengji Zonglu (General Medical Collection of Royal Benevolence) published in 1117 A.D. AMP-1915 consists of three herbs: Radix Astragali (roots of Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao, A), Mori Cortex radices (root barks of Morus alba L., M) and Puerariae Lobatae Radix (roots of Pueraria lobata (Willd.) Ohwi., P). Recent studies have shown that these three herbs and their constituents have therapeutic effects on the metabolic disorders. This randomized, double-blind, placebo-controlled trial was conducted in a community hospital of Shanghai, China. 60 adult participants were metabolic disorder patients according with at least two impaired metabolic profiles (obesity, hyperglycemia, hyperlipidemia or others). During 3-month treatment, participants were randomly divided in to two groups assigned to take AMP-1915 or placebo. AMP-1915 or placebo was mixed into instant noodles as daily meals with same color, shape, size and packaging. BMI, fasting blood glucose (FBG), triglyceride (TG), total cholesterol (TCH), high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein cholesterol (LDL-c), insulin, HbA1c were measured before and after treatment.

Conditions

Interventions

TypeNameDescription
DRUGAMP-1915A traditional Chinese Formula extract from Astragalus, Radix Puerariae and Cortex Mori is mixed into instant noodles. Patients are treated with AMP-1915 as meal.
OTHERPlaceboInstant noodles without drug

Timeline

Start date
2014-06-01
Primary completion
2014-12-01
Completion
2015-04-01
First posted
2015-11-16
Last updated
2016-01-07

Source: ClinicalTrials.gov record NCT02605655. Inclusion in this directory is not an endorsement.